Regulation of Estrogen Receptor α N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1

被引:62
|
作者
Rajbhandari, Prashant [1 ,2 ]
Finn, Greg [3 ]
Solodin, Natalia M. [1 ,2 ]
Singarapu, Kiran K. [4 ]
Sahu, Sarata C. [4 ]
Markley, John L. [4 ]
Kadunc, Kelley J. [1 ,2 ]
Ellison-Zelski, Stephanie J. [1 ,2 ]
Kariagina, Anastasia [5 ,6 ]
Haslam, Sandra Z. [5 ,6 ]
Lu, Kun Ping [3 ]
Alarid, Elaine T. [1 ,2 ]
机构
[1] Univ Wisconsin, Dept Oncol, Madison, WI 53715 USA
[2] Univ Wisconsin, UW Carbone Comprehens Canc Ctr, Madison, WI USA
[3] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Ctr Life Sci, Boston, MA USA
[4] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA
[5] Michigan State Univ, Dept Physiol & Breast Canc, E Lansing, MI 48824 USA
[6] Michigan State Univ, Environm Res Ctr, E Lansing, MI 48824 USA
关键词
CIS-TRANS ISOMERIZATION; BREAST-CANCER; TAMOXIFEN-RESISTANT; STEROID-RECEPTOR; ER-ALPHA; TRANSCRIPTIONAL ACTIVITY; POSTTRANSLATIONAL MODIFICATIONS; SIGNALING PATHWAYS; STRUCTURAL BASIS; GENE-EXPRESSION;
D O I
10.1128/MCB.06073-11
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estrogen receptor alpha (ER alpha), a key driver of growth in the majority of breast cancers, contains an unstructured transactivation domain (AF1) in its N terminus that is a convergence point for growth factor and hormonal activation. This domain is controlled by phosphorylation, but how phosphorylation impacts AF1 structure and function is unclear. We found that serine 118 (S118) phosphorylation of the ER alpha AF1 region in response to estrogen (agonist), tamoxifen (antagonist), and growth factors results in recruitment of the peptidyl prolyl cis/trans isomerase Pin1. Phosphorylation of S118 is critical for Pin1 binding, and mutation of S118 to alanine prevents this association. Importantly, Pin1 isomerizes the serine118-proline119 bond from a cis to trans isomer, with a concomitant increase in AF1 transcriptional activity. Pin1 overexpression promotes ligand-independent and tamoxifen-inducible activity of ER alpha and growth of tamoxifen-resistant breast cancer cells. Pin1 expression correlates with proliferation in ER alpha-positive rat mammary tumors. These results establish phosphorylation-coupled proline isomerization as a mechanism modulating AF1 functional activity and provide insight into the role of a conformational switch in the functional regulation of the intrinsically disordered transactivation domain of ER alpha.
引用
收藏
页码:445 / 457
页数:13
相关论文
共 50 条
  • [41] An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity
    Ieda, Naoya
    Itoh, Kaoru
    Inoue, Yasumichi
    Izumiya, Yusuke
    Kawaguchi, Mitusyasu
    Miyata, Naoki
    Nakagawa, Hidehiko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (03) : 353 - 356
  • [42] Interaction and Structural Modification of Topoisomerase IIα by Peptidyl Prolyl Isomerase, pin1: An In Silico Study
    Mathur, Rohit
    Suman, Shubhanker
    Beaume, Nicolas
    Ali, Mashook
    Bhatt, Anant N.
    Chopra, Madhu
    Saluja, Daman
    Mishra, Anil K.
    Chandna, Sudhir
    Kapoor, Pramesh N.
    Dwarakanath, Bilikere S.
    PROTEIN AND PEPTIDE LETTERS, 2010, 17 (02): : 151 - 163
  • [43] Functionally important residues in the peptidyl-prolyl isomerase Pin1 revealed by unigenic evolution
    Behrsin, C. D.
    Bailey, M. L.
    Bateman, K. S.
    Hamilton, K. S.
    Wahl, L. M.
    Brandl, C. J.
    Shilton, B. H.
    Litchfield, D. W.
    JOURNAL OF MOLECULAR BIOLOGY, 2007, 365 (04) : 1143 - 1162
  • [44] Expression of peptidyl-prolyl isomerase PIN1 and its role in the pathogenesis of extrahepatic cholangiocarcinoma
    Jamiyandorj, Urangoo
    Bae, Jun Sang
    Noh, Sang Jae
    Jachin, Sarangerel
    Choi, Ji Eun
    Jang, Kyu Yun
    Chung, Myoung Ja
    Kang, Myoung Jae
    Lee, Dong Geun
    Moon, Woo Sung
    ONCOLOGY LETTERS, 2013, 6 (05) : 1421 - 1426
  • [45] Pinning down signaling in the immune system: The role of the peptidyl-prolyl isomerase Pin1 in immune cell function
    Esnault, Stephane
    Shen, Zong-Jian
    Malter, James S.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2008, 28 (01) : 45 - 60
  • [46] A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1
    Jiang, Bisheng
    Pei, Dehua
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (15) : 6306 - 6312
  • [47] Overexpression of peptidyl-prolyl isomerase 1 (Pin1) and cyclin D1 in endometrial cancer
    Yan, Rongrong
    Wu, Xingguo
    Wang, Yongmei
    Yu, Chunli
    Li, Hua
    Zhang, Lan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03): : 3335 - 3343
  • [48] Requirement of the prolyl isomerase Pin1 for the replication checkpoint
    Winkler, KE
    Swenson, KI
    Kornbluth, S
    Means, AR
    SCIENCE, 2000, 287 (5458) : 1644 - 1647
  • [49] Targeting carcinogenesis: A role for the prolyl isomerase Pin1?
    Lu, Kun Ping
    Suizu, Futoshi
    Zhou, Xiao Zhen
    Finn, Greg
    Lam, Prudence
    Wulf, Gerburg
    MOLECULAR CARCINOGENESIS, 2006, 45 (06) : 397 - 402
  • [50] The prolyl isomerase Pin1 in breast development and cancer
    Wulf, G
    Ryo, A
    Liou, YC
    Lu, KP
    BREAST CANCER RESEARCH, 2003, 5 (02) : 76 - 82